Compare PRSU & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSU | ABCL |
|---|---|---|
| Founded | 1926 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.2M | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | PRSU | ABCL |
|---|---|---|
| Price | $33.44 | $4.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $31.67 | $7.75 |
| AVG Volume (30 Days) | 263.8K | ★ 4.2M |
| Earning Date | 11-05-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 902.95 | N/A |
| EPS | ★ 10.75 | N/A |
| Revenue | ★ $441,143,000.00 | $35,325,000.00 |
| Revenue This Year | $26.24 | $25.45 |
| Revenue Next Year | $8.08 | $10.07 |
| P/E Ratio | $3.27 | ★ N/A |
| Revenue Growth | 4.63 | ★ 7.17 |
| 52 Week Low | $26.66 | $1.89 |
| 52 Week High | $42.43 | $6.52 |
| Indicator | PRSU | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 58.74 |
| Support Level | $33.00 | $4.08 |
| Resistance Level | $34.49 | $4.66 |
| Average True Range (ATR) | 0.95 | 0.26 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 45.35 | 64.77 |
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.